No Data
No Data
InMed Pharmaceuticals Announces Upcoming AGM Date
InMed Pharmaceuticals Faces Nasdaq Delisting Challenge
Express News | InMed Pharmaceuticals: Receives Nasdaq Delisting Notice, Confirms It Has Filed Appeal & Obtained Panel Hearing Date
InMed Pharmaceuticals Shares Are Trading Higher After the Company Announced It Was Granted U.S. Patent US 12083229 B2 16/611837 for 'Ocular Drug Delivery Formulation'
Express News | InMed Pharmaceuticals Granted U.S. Patent US 12083229 B2 16/611837 For 'Ocular Drug Delivery Formulation'
Shares Of InMed Pharmaceuticals Seeing Increased Volume After Gene Online Article Circulating, "InMed Pharmaceuticals' Positive Market Response to Cannabinoid Analog INM-901 for Alzheimer's Treatment"
No Data
No Data